Eliminating Cervical Cancer in Asia–Pacific: From HPV Policy to Real-World Oncology Practice

Cervical cancer elimination is increasingly framed as a public health success story in the making, yet the clinical reality in Asia-Pacific tells a more sobering story.Globally, there were an estimated 660,000 new cervical cancer cases and 350,000 deaths in 2022, with the highest incidence and mortality in regions such as South-East Asia.1,2 In 2020 alone, the WHO South-East Asia Region accounted for about 200,000 new cases (32% of the global burden) and 100,000 deaths (34% of global deaths), while the Western Pacific Region contributed a further 145,700 cases and 74,900 deaths.3 The WHO Global Strategy defines elimination as reaching